AMATA Calls for all AU Member States to back the African Medicines Agency

AMATA Calls for all AU Member States to back the African Medicines Agency and for regulatory system strengthening to be recognised as a key element for a safer, healthier and prosperous Africa

October 24th, 2025, at the 4th Conference on Public Health in Africa – The members of the African Medicines Agency Treaty Alliance (AMATA) call on all the Member States of the African Union to actively support the African Medicines Agency and seize this historic opportunity to improve access to quality, safe and efficacious medicines and vaccines on the Continent.

Invested by the power of civil society, community actors and the private sector, we now call upon the African Union and its Member States to ensure that:

1. The AMA Treaty is unanimously ratified by all 54 AU Member States to confer the legitimacy that it deserves to provide a unified Continental regulatory oversight in Africa.

2. AMA builds and reinforces the African regulatory ecosystem that exists at national and regional levels, to work in collaboration and reinforce each other’s capacities.

3. The pharmaceutical regulatory processes are streamlined to prevent duplication of efforts and delays in access to life-saving medicines and vaccines for all patients.

4. AMA contributes to combating falsified and substandard medicinal products on the Continent by means of enhanced market surveillance, centralised information collection and data sharing amongst African countries.

5. AMA becomes a modern regulatory agency that adopts digital solutions and reliance-based procedures to accelerate access to health products and vaccines.

6. AMA receives sustainable funding and is equipped with adequate human resources capacity to fulfil its mandate.

7. A framework for engagement with patients and non-state actors is set up early on to foster multi-stakeholder collaboration and leverage all available resources and expertise.